Cardiac function in growth hormone deficient patients before and after 1 year with replacement therapy: a magnetic resonance imaging study

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Cardiac function in growth hormone deficient patients before and after 1 year with replacement therapy: a magnetic resonance imaging study. / Andreassen, Mikkel; Faber, Jens Oscar; Kjær, Andreas; Petersen, Claus Leth; Kristensen, Lars Østergaard; Kjær, Andreas.

In: Pituitary, Vol. 14, No. 1, 01.03.2011, p. 1-10.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Andreassen, M, Faber, JO, Kjær, A, Petersen, CL, Kristensen, LØ & Kjær, A 2011, 'Cardiac function in growth hormone deficient patients before and after 1 year with replacement therapy: a magnetic resonance imaging study', Pituitary, vol. 14, no. 1, pp. 1-10. https://doi.org/10.1007/s11102-010-0250-7, https://doi.org/10.1007/s11102-010-0250-7

APA

Andreassen, M., Faber, J. O., Kjær, A., Petersen, C. L., Kristensen, L. Ø., & Kjær, A. (2011). Cardiac function in growth hormone deficient patients before and after 1 year with replacement therapy: a magnetic resonance imaging study. Pituitary, 14(1), 1-10. https://doi.org/10.1007/s11102-010-0250-7, https://doi.org/10.1007/s11102-010-0250-7

Vancouver

Andreassen M, Faber JO, Kjær A, Petersen CL, Kristensen LØ, Kjær A. Cardiac function in growth hormone deficient patients before and after 1 year with replacement therapy: a magnetic resonance imaging study. Pituitary. 2011 Mar 1;14(1):1-10. https://doi.org/10.1007/s11102-010-0250-7, https://doi.org/10.1007/s11102-010-0250-7

Author

Andreassen, Mikkel ; Faber, Jens Oscar ; Kjær, Andreas ; Petersen, Claus Leth ; Kristensen, Lars Østergaard ; Kjær, Andreas. / Cardiac function in growth hormone deficient patients before and after 1 year with replacement therapy: a magnetic resonance imaging study. In: Pituitary. 2011 ; Vol. 14, No. 1. pp. 1-10.

Bibtex

@article{7063a7c4044b4611b8a7cfa415af745b,
title = "Cardiac function in growth hormone deficient patients before and after 1 year with replacement therapy: a magnetic resonance imaging study",
abstract = "Assessed by conventional echocardiography the influence of growth hormone deficiency (GHD) and effects of replacement therapy on left ventricle (LV) function and mass (LVM) have shown inconsistent results. We aimed to evaluate cardiac function before and during replacement therapy employing the gold standard method cardiac magnetic resonance imaging (CMRI) and measurements of circulating levels of B-type natriuretic peptides. Sixteen patients (8 males and 8 females, mean age 49 years (range 18-75)) with severe GHD and 16 matched control subjects were included. CMRI was performed at baseline and after 1 year of GH replacement therapy. IGF-I, B-type natriuretic peptide (BNP) and N-terminal pro-BNP (NT-proBNP) were measured after 0, 1, 2, 3, 6 and 12 months of treatment. IGF-I Z-score increased from (median (IQR)) -2.3 (-3.8 to -1.4) to 0.5 (-0.3 to 1.7). LVM index (LVMI), ejection fraction (range 63-80{\%}), cardiac output index and levels of BNP and NT-proBNP were similar at baseline in patients compared to controls (P-values from 0.09 to 0.37). The patients had significantly smaller LV end-diastolic volume index (P = 0.032) and end-systolic volume index (P = 0.038). No significant change in LV systolic function or LVM occurred during 1 year of GH treatment. BNP levels were unchanged (P = 0.88), whereas NT-proBNP tended to decrease (P = 0.052). Assessed by the highly sensitive and precise CMRI method, untreated GHD was not associated with impaired systolic function or reduced LVMI and 1 year of GH replacement using physiological doses did not influence cardiac mass or function.",
author = "Mikkel Andreassen and Faber, {Jens Oscar} and Andreas Kj{\ae}r and Petersen, {Claus Leth} and Kristensen, {Lars {\O}stergaard} and Andreas Kj{\ae}r",
year = "2011",
month = "3",
day = "1",
doi = "10.1007/s11102-010-0250-7",
language = "English",
volume = "14",
pages = "1--10",
journal = "Pituitary",
issn = "1386-341X",
publisher = "Springer",
number = "1",

}

RIS

TY - JOUR

T1 - Cardiac function in growth hormone deficient patients before and after 1 year with replacement therapy: a magnetic resonance imaging study

AU - Andreassen, Mikkel

AU - Faber, Jens Oscar

AU - Kjær, Andreas

AU - Petersen, Claus Leth

AU - Kristensen, Lars Østergaard

AU - Kjær, Andreas

PY - 2011/3/1

Y1 - 2011/3/1

N2 - Assessed by conventional echocardiography the influence of growth hormone deficiency (GHD) and effects of replacement therapy on left ventricle (LV) function and mass (LVM) have shown inconsistent results. We aimed to evaluate cardiac function before and during replacement therapy employing the gold standard method cardiac magnetic resonance imaging (CMRI) and measurements of circulating levels of B-type natriuretic peptides. Sixteen patients (8 males and 8 females, mean age 49 years (range 18-75)) with severe GHD and 16 matched control subjects were included. CMRI was performed at baseline and after 1 year of GH replacement therapy. IGF-I, B-type natriuretic peptide (BNP) and N-terminal pro-BNP (NT-proBNP) were measured after 0, 1, 2, 3, 6 and 12 months of treatment. IGF-I Z-score increased from (median (IQR)) -2.3 (-3.8 to -1.4) to 0.5 (-0.3 to 1.7). LVM index (LVMI), ejection fraction (range 63-80%), cardiac output index and levels of BNP and NT-proBNP were similar at baseline in patients compared to controls (P-values from 0.09 to 0.37). The patients had significantly smaller LV end-diastolic volume index (P = 0.032) and end-systolic volume index (P = 0.038). No significant change in LV systolic function or LVM occurred during 1 year of GH treatment. BNP levels were unchanged (P = 0.88), whereas NT-proBNP tended to decrease (P = 0.052). Assessed by the highly sensitive and precise CMRI method, untreated GHD was not associated with impaired systolic function or reduced LVMI and 1 year of GH replacement using physiological doses did not influence cardiac mass or function.

AB - Assessed by conventional echocardiography the influence of growth hormone deficiency (GHD) and effects of replacement therapy on left ventricle (LV) function and mass (LVM) have shown inconsistent results. We aimed to evaluate cardiac function before and during replacement therapy employing the gold standard method cardiac magnetic resonance imaging (CMRI) and measurements of circulating levels of B-type natriuretic peptides. Sixteen patients (8 males and 8 females, mean age 49 years (range 18-75)) with severe GHD and 16 matched control subjects were included. CMRI was performed at baseline and after 1 year of GH replacement therapy. IGF-I, B-type natriuretic peptide (BNP) and N-terminal pro-BNP (NT-proBNP) were measured after 0, 1, 2, 3, 6 and 12 months of treatment. IGF-I Z-score increased from (median (IQR)) -2.3 (-3.8 to -1.4) to 0.5 (-0.3 to 1.7). LVM index (LVMI), ejection fraction (range 63-80%), cardiac output index and levels of BNP and NT-proBNP were similar at baseline in patients compared to controls (P-values from 0.09 to 0.37). The patients had significantly smaller LV end-diastolic volume index (P = 0.032) and end-systolic volume index (P = 0.038). No significant change in LV systolic function or LVM occurred during 1 year of GH treatment. BNP levels were unchanged (P = 0.88), whereas NT-proBNP tended to decrease (P = 0.052). Assessed by the highly sensitive and precise CMRI method, untreated GHD was not associated with impaired systolic function or reduced LVMI and 1 year of GH replacement using physiological doses did not influence cardiac mass or function.

U2 - 10.1007/s11102-010-0250-7

DO - 10.1007/s11102-010-0250-7

M3 - Journal article

VL - 14

SP - 1

EP - 10

JO - Pituitary

JF - Pituitary

SN - 1386-341X

IS - 1

ER -

ID: 34085741